Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

4.05
Delayed Data
As of Mar 27
 +0.05 / +1.25%
Today’s Change
3.80
Today|||52-Week Range
7.94
-3.57%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close4.00
Today’s open3.90
Day’s range3.90 - 4.10
Volume90,215
Average volume (3 months)182,205
Market cap$128.4M
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+39.68%
Earnings growth (this year)-0.64%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.43

Competitors

 Today’s
change
Today’s
% change
PFNXPfenex Inc+0.20+3.57%
EVGNEvogene Ltd+0.06+1.16%
PLXProtalix Biotherapeu...+0.05+4.46%
PSTIPluristem Therapeuti...-0.02-1.65%
Data as of 4:02pm ET, 03/27/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$23.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs